Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Synsorb Biotech licenses technology for enteropathogenic E. coli infection treatment

July 26, 1996

No Comments

StressGen acquires rights to gene therapy technology

July 26, 1996

No Comments

Somatix acquires exclusive license to gene transfer technology

July 26, 1996

No Comments

Guilford obtains rights to chemotherapy drug delivery system

July 26, 1996

No Comments

Ribozyme/Alza research collaboration

July 26, 1996

No Comments

Techniclone International issued European patent for its Modified Antibodies Technology

July 26, 1996

No Comments

Isis and ProtoGene renew drug discovery collaboration

July 26, 1996

No Comments

Millennium and Wyeth-Ayerst collaborate on CNS drugs and gene therapies

July 26, 1996

No Comments

Biogen and Ontogeny sign CNS drug development collaboration

July 26, 1996

No Comments

Ontogen and Kanebo enter drug development collaboration

July 26, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies, BioWorld Science
RSS

Synsorb Biotech licenses technology for enteropathogenic E. coli infection treatment

StressGen acquires rights to gene therapy technology

Somatix acquires exclusive license to gene transfer technology

Guilford obtains rights to chemotherapy drug delivery system

Ribozyme/Alza research collaboration

Techniclone International issued European patent for its Modified Antibodies Technology

Isis and ProtoGene renew drug discovery collaboration

Millennium and Wyeth-Ayerst collaborate on CNS drugs and gene therapies

Biogen and Ontogeny sign CNS drug development collaboration

Ontogen and Kanebo enter drug development collaboration

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Drug design, drug delivery and technologies, BioWorld Science RSS

Drug design, drug delivery and technologies, BioWorld Science
RSS